[1]
Hashim, H.O. et al. 2025. Repurposing FDA-approved drugs against the Crimean-Congo haemorrhagic fever virus: an in silico study. Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.208.